534 related articles for article (PubMed ID: 28582760)
1. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review.
Anjum K; Shagufta BI; Abbas SQ; Patel S; Khan I; Shah SAA; Akhter N; Hassan SSU
Biomed Pharmacother; 2017 Aug; 92():681-689. PubMed ID: 28582760
[TBL] [Abstract][Full Text] [Related]
2. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
[TBL] [Abstract][Full Text] [Related]
3. Emerging therapeutic targets and agents for glioblastoma migrating cells.
Di C; Mattox AK; Harward S; Adamson C
Anticancer Agents Med Chem; 2010 Sep; 10(7):543-55. PubMed ID: 20950259
[TBL] [Abstract][Full Text] [Related]
4. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
Wang G; Wang J; Zhao H; Wang J; Tony To SS
Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
[TBL] [Abstract][Full Text] [Related]
5. A novel treatment for glioblastoma: integrin inhibition.
Chamberlain MC; Cloughsey T; Reardon DA; Wen PY
Expert Rev Neurother; 2012 Apr; 12(4):421-35. PubMed ID: 22449214
[TBL] [Abstract][Full Text] [Related]
6. Necroptosis: a novel therapeutic target for glioblastoma.
Jiang YG; Peng Y; Koussougbo KS
Med Hypotheses; 2011 Mar; 76(3):350-2. PubMed ID: 21075544
[TBL] [Abstract][Full Text] [Related]
7. The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review.
Mohtashami E; Shafaei-Bajestani N; Mollazadeh H; Mousavi SH; Jalili-Nik M; Sahebkar A; Afshari AR
Curr Drug Metab; 2020; 21(8):564-578. PubMed ID: 32664839
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms regulating glioma invasion.
Paw I; Carpenter RC; Watabe K; Debinski W; Lo HW
Cancer Lett; 2015 Jun; 362(1):1-7. PubMed ID: 25796440
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids in the treatment of glioblastoma.
Buchalska B; Kamińska K; Owe-Larsson M; Cudnoch-Jędrzejewska A
Pharmacol Rep; 2024 Apr; 76(2):223-234. PubMed ID: 38457018
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic advances for glioblastoma multiforme: current status and future prospects.
Robins HI; Chang S; Butowski N; Mehta M
Curr Oncol Rep; 2007 Jan; 9(1):66-70. PubMed ID: 17164050
[TBL] [Abstract][Full Text] [Related]
12. Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme.
Akhter MH; Rizwanullah M; Ahmad J; Amin S; Ahmad MZ; Minhaj MA; Mujtaba MA; Ali J
Drug Res (Stuttg); 2021 Mar; 71(3):122-137. PubMed ID: 33167048
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy.
Wang S; Gu S; Chen J; Yuan Z; Liang P; Cui H
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672496
[TBL] [Abstract][Full Text] [Related]
14. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).
Bryukhovetskiy I; Ponomarenko A; Lyakhova I; Zaitsev S; Zayats Y; Korneyko M; Eliseikina M; Mischenko P; Shevchenko V; Shanker Sharma H; Sharma A; Khotimchenko Y
Int J Mol Med; 2018 Aug; 42(2):691-702. PubMed ID: 29749540
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.
Abhinav K; Aquilina K; Gbejuade H; La M; Hopkins K; Iyer V
Clin Neurol Neurosurg; 2013 Aug; 115(8):1375-8. PubMed ID: 23333005
[TBL] [Abstract][Full Text] [Related]
16. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme.
Bambury RM; Morris PG
Expert Rev Anticancer Ther; 2014 Aug; 14(8):955-64. PubMed ID: 24814143
[TBL] [Abstract][Full Text] [Related]
17. The Multifaceted Metabolism of Glioblastoma.
Quinones A; Le A
Adv Exp Med Biol; 2018; 1063():59-72. PubMed ID: 29946775
[TBL] [Abstract][Full Text] [Related]
18. Success and Failures of Combined Modalities in Glioblastoma Multiforme: Old Problems and New Directions.
Corso CD; Bindra RS
Semin Radiat Oncol; 2016 Oct; 26(4):281-98. PubMed ID: 27619250
[TBL] [Abstract][Full Text] [Related]
19. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
Vymazal J; Wong ET
Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
[TBL] [Abstract][Full Text] [Related]
20. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
